Save items
Add to Favorites
loading
Similar articles in PubMed
Recreational and ergogenic substance use and substance use disorders in elite athletes: a narrative review.
[Br J Sports Med. 2019]
McDuff D, Stull T, Castaldelli-Maia JM, Hitchcock ME, Hainline B, Reardon CL.
Br J Sports Med. 2019 Jun; 53(12):754-760. Epub 2019 May 16.
Prevalence and correlates of cannabis use among athletes-A systematic review.
[Am J Addict. 2016]
Brisola-Santos MB, Gallinaro JG, Gil F, Sampaio-Junior B, Marin MC, de Andrade AG, Richter KP, Glick ID, Baltieri DA, Castaldelli-Maia JM.
Am J Addict. 2016 Oct; 25(7):518-28. Epub 2016 Sep 15.
Cannabis and Cannabinoids for Chronic Pain.
[Curr Rheumatol Rep. 2017]
Romero-Sandoval EA, Kolano AL, Alvarado-Vázquez PA.
Curr Rheumatol Rep. 2017 Oct 5; 19(11):67. Epub 2017 Oct 5.
Cannabis and schizophrenia.
[Cochrane Database Syst Rev. 2014]
McLoughlin BC, Pushpa-Rajah JA, Gillies D, Rathbone J, Variend H, Kalakouti E, Kyprianou K.
Cochrane Database Syst Rev. 2014 Oct 14; (10):CD004837. Epub 2014 Oct 14.
Treating the elite athlete: anti-doping information for the health professional.
[Mo Med. 2015]
Tandon S, Bowers LD, Fedoruk MN.
Mo Med. 2015 Mar-Apr; 112(2):122-8.
See reviews...
See all...
Cited by other articles in PMC
A Warning against the Negligent Use of Cannabidiol in Professional and Amateur Athletes
[Sports. 2019]
Lachenmeier DW, Diel P.
Sports. 2019 Dec 14; 7(12): 251
See all...
Links
Compound
Compound
PubChem Compound links
MedGen
MedGen
Related information in MedGen
PubMed
PubMed
PubMed citations for these articles
Taxonomy
Taxonomy
Related taxonomy entry
Recent Activity
Clear
Turn Off
Turn On
Cannabis and the Health and Performance of the Elite Athlete
Cannabis and the Health and Performance of the Elite Athlete
Lippincott Williams & Wilkins Open Access. 2018 Sep; 28(5)480
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on
See more...
Review
Cannabis: Exercise performance and sport. A systematic review.
[J Sci Med Sport. 2017]
Kennedy MC
J Sci Med Sport. 2017 Sep; 20(9):825-829.
Review
Cannabinoids in health and disease.
[Dialogues Clin Neurosci. 2007]
Kogan NM, Mechoulam R
Dialogues Clin Neurosci. 2007; 9(4):413-30.
Hashish. IV. The isolation and structure of cannabinolic cannabidiolic and cannabigerolic acids.
[Tetrahedron. 1965]
Mechoulam R, Gaoni Y
Tetrahedron. 1965 May; 21(5):1223-9.
Effects of smoked marijuana in experimentally induced asthma.
[Am Rev Respir Dis. 1975]
Tashkin DP, Shapiro BJ, Lee YE, Harper CE
Am Rev Respir Dis. 1975 Sep; 112(3):377-86.
Marihuana: studies on the disposition and metabolism of delta-9-tetrahydrocannabinol in man.
[Science. 1970]
Lemberger L, Silberstein SD, Axelrod J, Kopin IJ
Science. 1970 Dec 18; 170(3964):1320-2.
Review
Marihuana vs. alcohol: a pharmacologic comparison.
[Adv Exp Med Biol. 1975]
Truitt EB Jr
Adv Exp Med Biol. 1975; 56():291-309.
Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.
[J Pain. 2012]
Portenoy RK, Ganae-Motan ED, Allende S, Yanagihara R, Shaiova L, Weinstein S, McQuade R, Wright S, Fallon MT
J Pain. 2012 May; 13(5):438-49.
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.
[N Engl J Med. 2017]
Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, Scheffer IE, Thiele EA, Wright S, Cannabidiol in Dravet Syndrome Study Group.
N Engl J Med. 2017 May 25; 376(21):2011-2020.
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
[Lancet. 2018]
Thiele EA, Marsh ED, French JA, Mazurkiewicz-Beldzinska M, Benbadis SR, Joshi C, Lyons PD, Taylor A, Roberts C, Sommerville K, GWPCARE4 Study Group.
Lancet. 2018 Mar 17; 391(10125):1085-1096.
Review
The role of the endocannabinoid system in pain.
[Handb Exp Pharmacol. 2015]
Woodhams SG, Sagar DR, Burston JJ, Chapman V
Handb Exp Pharmacol. 2015; 227():119-43.
An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee.
[Pain. 2012]
Huggins JP, Smart TS, Langman S, Taylor L, Young T
Pain. 2012 Sep; 153(9):1837-46.
A randomized, controlled study to investigate the analgesic efficacy of single doses of the cannabinoid receptor-2 agonist GW842166, ibuprofen or placebo in patients with acute pain following third molar tooth extraction.
[Clin J Pain. 2011]
Ostenfeld T, Price J, Albanese M, Bullman J, Guillard F, Meyer I, Leeson R, Costantin C, Ziviani L, Nocini PF, Milleri S
Clin J Pain. 2011 Oct; 27(8):668-76.
Review
Annual banned-substance review: analytical approaches in human sports drug testing.
[Drug Test Anal. 2014]
Thevis M, Kuuranne T, Geyer H, Schänzer W
Drug Test Anal. 2014 Jan-Feb; 6(1-2):164-84.
Sporting activity and drug use: Alcohol, cigarette and cannabis use among elite student athletes.
[Addiction. 2003]
Peretti-Watel P, Guagliardo V, Verger P, Pruvost J, Mignon P, Obadia Y
Addiction. 2003 Sep; 98(9):1249-56.
Review
Prevalence and correlates of cannabis use among athletes-A systematic review.
[Am J Addict. 2016]
Brisola-Santos MB, Gallinaro JG, Gil F, Sampaio-Junior B, Marin MC, de Andrade AG, Richter KP, Glick ID, Baltieri DA, Castaldelli-Maia JM
Am J Addict. 2016 Oct; 25(7):518-28.
Review
Prevalence and correlates of cannabis use among athletes-A systematic review.
[Am J Addict. 2016]
Brisola-Santos MB, Gallinaro JG, Gil F, Sampaio-Junior B, Marin MC, de Andrade AG, Richter KP, Glick ID, Baltieri DA, Castaldelli-Maia JM
Am J Addict. 2016 Oct; 25(7):518-28.
Drugs and the college athlete: an analysis of the attitudes of student athletes at risk.
[J Drug Educ. 1997]
Tricker R, Connolly D
J Drug Educ. 1997; 27(2):105-19.
The prevalence of doping in Flanders in comparison to the prevalence of doping in international sports.
[Int J Sports Med. 2003]
Van Eenoo P, Delbeke FT
Int J Sports Med. 2003 Nov; 24(8):565-70.
Cannabis use, sport practice and other leisure activities at the end of adolescence.
[Drug Alcohol Depend. 2004]
Peretti-Watel P, Lorente FO
Drug Alcohol Depend. 2004 Mar 8; 73(3):251-7.
Review
Prevalence and correlates of cannabis use among athletes-A systematic review.
[Am J Addict. 2016]
Brisola-Santos MB, Gallinaro JG, Gil F, Sampaio-Junior B, Marin MC, de Andrade AG, Richter KP, Glick ID, Baltieri DA, Castaldelli-Maia JM
Am J Addict. 2016 Oct; 25(7):518-28.
The effects of smoking marihuana on physical performance.
[Med Sci Sports. 1975]
Steadward RD, Singh M
Med Sci Sports. 1975 Winter; 7(4):309-11.
Acute effects of marihuana smoking on maximal exercise performance.
[Med Sci Sports Exerc. 1986]
Renaud AM, Cormier Y
Med Sci Sports Exerc. 1986 Dec; 18(6):685-9.
Drug misuse by adolescent athletes.
[Pediatr Clin North Am. 1982]
Dyment PG
Pediatr Clin North Am. 1982 Dec; 29(6):1363-8.
Review
Ergolytic drugs in medicine and sports.
[Am J Med. 1993]
Eichner ER
Am J Med. 1993 Feb; 94(2):205-11.
Cannabis use to enhance sportive and non-sportive performances among French sport students.
[Addict Behav. 2005]
Lorente FO, Peretti-Watel P, Grelot L
Addict Behav. 2005 Aug; 30(7):1382-91.
Review
Cannabis and sport.
[Br J Sports Med. 2006]
Saugy M, Avois L, Saudan C, Robinson N, Giroud C, Mangin P, Dvorak J
Br J Sports Med. 2006 Jul; 40 Suppl 1():i13-5.
Review
Pain perception in athletes compared to normally active controls: a systematic review with meta-analysis.
[Pain. 2012]
Tesarz J, Schuster AK, Hartmann M, Gerhardt A, Eich W
Pain. 2012 Jun; 153(6):1253-62.
Why should Cannabis be Considered Doping in Sports?
[Front Psychiatry. 2013]
Bergamaschi MM, Crippa JA
Front Psychiatry. 2013; 4():32.
Performance-enhancing drugs, fair competition, and Olympic sport.
[JAMA. 1996]
Catlin DH, Murray TH
JAMA. 1996 Jul 17; 276(3):231-7.
Review
Marijuana as doping in sports.
[Sports Med. 2003]
Campos DR, Yonamine M, de Moraes Moreau RL
Sports Med. 2003; 33(6):395-9.
Review
Cannabis: Exercise performance and sport. A systematic review.
[J Sci Med Sport. 2017]
Kennedy MC
J Sci Med Sport. 2017 Sep; 20(9):825-829.
Review
High-performance sport, marijuana, and cannabimimetics.
[J Anal Toxicol. 2011]
Hilderbrand RL
J Anal Toxicol. 2011 Nov; 35(9):624-37.
Review
Cannabis in sport: anti-doping perspective.
[Sports Med. 2011]
Huestis MA, Mazzoni I, Rabin O
Sports Med. 2011 Nov 1; 41(11):949-66.
Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study.
[Am J Phys Med Rehabil. 2010]
Rintala DH, Fiess RN, Tan G, Holmes SA, Bruel BM
Am J Phys Med Rehabil. 2010 Oct; 89(10):840-8.
A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury.
[Arch Phys Med Rehabil. 2010]
Pooyania S, Ethans K, Szturm T, Casey A, Perry D
Arch Phys Med Rehabil. 2010 May; 91(5):703-7.
Cannabis effect on spasticity in spinal cord injury.
[Arch Phys Med Rehabil. 1982]
Malec J, Harvey RF, Cayner JJ
Arch Phys Med Rehabil. 1982 Mar; 63(3):116-8.
Review
Cannabinoids and glaucoma.
[Br J Ophthalmol. 2004]
Tomida I, Pertwee RG, Azuara-Blanco A
Br J Ophthalmol. 2004 May; 88(5):708-13.
Review
Adverse health effects of marijuana use.
[N Engl J Med. 2014]
Volkow ND, Baler RD, Compton WM, Weiss SR
N Engl J Med. 2014 Jun 5; 370(23):2219-27.
Review
Adverse effects of medical cannabinoids: a systematic review.
[CMAJ. 2008]
Wang T, Collet JP, Shapiro S, Ware MA
CMAJ. 2008 Jun 17; 178(13):1669-78.
Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS).
[J Pain. 2015]
Ware MA, Wang T, Shapiro S, Collet JP, COMPASS study team.
J Pain. 2015 Dec; 16(12):1233-1242.